Skip to main content

Table 2 Comparison of primary and secondary outcomes between the treatment and control groups

From: Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus

Outcome

Treatment group

Control group

P-value

Tumor responseb

n = 29

n = 53

0.61

 Complete response

2 (7)

6 (11.3)

 

 Partial response

9 (31)

5 (9.4)

 

 Stable disease

12 (41.3)

35 (66.1)

 

 Progressive disease

6 (20.7)

7 (13.2)

 

Portal vein tumor thrombus responseb

n = 29

n = 53

< 0.001

 Grade 3

6 (20.7)

1 (1.9)

 

 Grade 2

15 (51.7)

6 (11.3)

 

 Grade 1

6(20.7)

10 (18.9)

 

 Grade 0

2 (6.9)

36 (67.9)

 

Overall survival (%)

n = 31

n = 57

0.001

 At 3-months

90.3

59.6

 

 At 6-months

64.5

29.8

 

 At 12-months

41.9

10.6

 
  1. Values are depicted as n (%)
  2. bBefore the statistics were performed, two patients died in treatment group and control group, respectively